Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats

Because of high mortality caused by cardiovascular diseases, various fibrinolytic agents with diverse pharmacokinetic and pharmacodynamic properties have been developed. A novel mutated chimeric tissue plasminogen activator (mt-PA) was developed by the removal of first three domains of t-PA, inserti...

Descripción completa

Detalles Bibliográficos
Autores principales: Raigani, Mozhgan, Rouini, Mohammad-Reza, Golabchifar, Ali-Akbar, Mirabzadeh, Esmat, Vaziri, Behrouz, Barkhordari, Farzaneh, Davami, Fatemeh, Mahboudi, Fereidoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320447/
https://www.ncbi.nlm.nih.gov/pubmed/28223717
http://dx.doi.org/10.1038/srep43028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320447/
https://www.ncbi.nlm.nih.gov/pubmed/28223717
http://dx.doi.org/10.1038/srep43028

Ejemplares similares